ArticleOncogene2019
Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Hanna Karvonen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it